Novo Holdings A/S

Holdings History for Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

Symbol: SPRO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-0.03%	$0	0	-468,902	-100%	$2.37	Q4 2024
30 Sep 2024	0.03%	0%	$628,329	468,902	0		$1.34	Q3 2024
30 Jun 2024	0.03%	0%	$609,573	468,902	0		$1.30	Q2 2024
31 Mar 2024	0.06%	0%	$806,511	468,902	0		$1.72	Q1 2024
31 Dec 2023		0%	$123,386,872	468,902	0		$263.14 ^*	Q4 2023
30 Sep 2023	0.04%	0%	$567,371	468,902	0		$1.21	Q3 2023
30 Jun 2023	0.05%	0%	$679,908	468,902	0		$1.45	Q2 2023
31 Mar 2023	0.05%	0%	$679,908	468,902	0		$1.45	Q1 2023
31 Dec 2022	0.05%	0%	$811,200	468,902	0		$1.73	Q4 2022
30 Sep 2022	0.06%	0%	$938,000	468,902	0		$2.00	Q3 2022
30 Jun 2022	0.02%	0%	$347,000	468,902	0		$0.74	Q2 2022
31 Mar 2022	0.22%	0%	$4,079,000	468,902	0		$8.70	Q1 2022
31 Dec 2021	0.36%	0%	$7,507,000	468,902	0		$16.01	Q4 2021
30 Sep 2021	0.45%	0%	$8,632,000	468,902	0		$18.41	Q3 2021
30 Jun 2021	0.29%	0%	$6,546,000	468,902	0		$13.96	Q2 2021
31 Mar 2021	0.29%	-0.07%	$6,902,000	468,902	-107,800	-19%	$14.72	Q1 2021
31 Dec 2020	0.48%	-0.29%	$11,182,000	576,702	-354,397	-38%	$19.39	Q4 2020
30 Sep 2020	0.52%	0%	$10,391,000	931,099	0		$11.16	Q3 2020
30 Jun 2020	0.81%	0%	$12,598,000	931,099	0		$13.53	Q2 2020
31 Mar 2020	0.53%	0%	$7,523,000	931,099	0		$8.08	Q1 2020
31 Dec 2019	0.58%	+0.29%	$8,948,000	931,099	+465,116	+100%	$9.61	Q4 2019
30 Sep 2019	0.86%	0%	$4,939,000	465,983	0		$10.60	Q3 2019
30 Jun 2019	0.75%	+0.75%	$5,363,000	465,983	+465,983	NEW	$11.51	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.